151 related articles for article (PubMed ID: 12133721)
21. Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation.
Reich SH; Johnson T; Wallace MB; Kephart SE; Fuhrman SA; Worland ST; Matthews DA; Hendrickson TF; Chan F; Meador J; Ferre RA; Brown EL; DeLisle DM; Patick AK; Binford SL; Ford CE
J Med Chem; 2000 May; 43(9):1670-83. PubMed ID: 10794684
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease.
Tiew KC; He G; Aravapalli S; Mandadapu SR; Gunnam MR; Alliston KR; Lushington GH; Kim Y; Chang KO; Groutas WC
Bioorg Med Chem Lett; 2011 Sep; 21(18):5315-9. PubMed ID: 21802286
[TBL] [Abstract][Full Text] [Related]
23. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
[TBL] [Abstract][Full Text] [Related]
24. Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents.
Tripathy R; Ator MA; Mallamo JP
Bioorg Med Chem Lett; 2000 Oct; 10(20):2315-9. PubMed ID: 11055346
[TBL] [Abstract][Full Text] [Related]
25. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.
Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Reich SH; Marakovits JT; Prins TJ; Zhou R; Tikhe J; Littlefield ES; Bleckman TM; Wallace MB; Little TL; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; DeLisle DM; Worland ST
J Med Chem; 1998 Jul; 41(15):2819-34. PubMed ID: 9667971
[TBL] [Abstract][Full Text] [Related]
26. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
[TBL] [Abstract][Full Text] [Related]
27. An updated patent review of calpain inhibitors (2012 - 2014).
Donkor IO
Expert Opin Ther Pat; 2015 Jan; 25(1):17-31. PubMed ID: 25399719
[TBL] [Abstract][Full Text] [Related]
28. Polymer-supported approach for solution-phase synthesis of cysteine trap protease inhibitors: procedure for straightforward optimization of the P1-P1' pocket.
Yadav-Bhatnagar N; Desjonquères N; Mauger J
J Comb Chem; 2002; 4(1):49-55. PubMed ID: 11831882
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of a library of thiocarbazates and their activity as cysteine protease inhibitors.
Liu Z; Myers MC; Shah PP; Beavers MP; Benedetti PA; Diamond SL; Smith AB; Huryn DM
Comb Chem High Throughput Screen; 2010 May; 13(4):337-51. PubMed ID: 20438448
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
[TBL] [Abstract][Full Text] [Related]
32. New anti-viral drugs for the treatment of the common cold.
Maugeri C; Alisi MA; Apicella C; Cellai L; Dragone P; Fioravanzo E; Florio S; Furlotti G; Mangano G; Ombrato R; Luisi R; Pompei R; Rincicotti V; Russo V; Vitiello M; Cazzolla N
Bioorg Med Chem; 2008 Mar; 16(6):3091-107. PubMed ID: 18248816
[TBL] [Abstract][Full Text] [Related]
33. A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.
Kathman SG; Xu Z; Statsyuk AV
J Med Chem; 2014 Jun; 57(11):4969-74. PubMed ID: 24870364
[TBL] [Abstract][Full Text] [Related]
34. Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.
Ando R; Sakaki T; Morinaka Y; Takahashi C; Tamao Y; Yoshii N; Katayama S; Saito K; Tokuyama H; Isaka M; Nakamura E
Bioorg Med Chem; 1999 Apr; 7(4):571-9. PubMed ID: 10353636
[TBL] [Abstract][Full Text] [Related]
35. Solution phase synthesis of a combinatorial library of chalcones and flavones as potent cathepsin V inhibitors.
Alvim J; Severino RP; Marques EF; Martinelli AM; Vieira PC; Fernandes JB; da Silva MF; Corrêa AG
J Comb Chem; 2010 Sep; 12(5):687-95. PubMed ID: 20578711
[TBL] [Abstract][Full Text] [Related]
36. Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors.
Abell AD; Jones MA; Coxon JM; Morton JD; Aitken SG; McNabb SB; Lee HY; Mehrtens JM; Alexander NA; Stuart BG; Neffe AT; Bickerstaffe R
Angew Chem Int Ed Engl; 2009; 48(8):1455-8. PubMed ID: 19145612
[TBL] [Abstract][Full Text] [Related]
37. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
[TBL] [Abstract][Full Text] [Related]
38. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
[TBL] [Abstract][Full Text] [Related]
39. Cysteine protease inhibitors: from evolutionary relationships to modern chemotherapeutic design for the treatment of infectious diseases.
Toh EC; Huq NL; Dashper SG; Reynolds EC
Curr Protein Pept Sci; 2010 Dec; 11(8):725-43. PubMed ID: 21235508
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease.
Johnson TO; Hua Y; Luu HT; Brown EL; Chan F; Chu SS; Dragovich PS; Eastman BW; Ferre RA; Fuhrman SA; Hendrickson TF; Maldonado FC; Matthews DA; Meador JW; Patick AK; Reich SH; Skalitzky DJ; Worland ST; Yang M; Zalman LS
J Med Chem; 2002 May; 45(10):2016-23. PubMed ID: 11985469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
